Medgend Icon







discontinued


Camptosar FDA Approved Drugs

CAMPTOSAR [Irinotecan HydrochlorideC33H38N4O6ClH3H2O]
RX
-
100mg/5ml (20mg/ml) (injection injectable)
300mg/15ml (20mg/ml) (injection injectable)
40mg/2ml (20mg/ml) (injection injectable)
Pfizer IncJun 14, 1996
  • Use in combination with 5-fluorouracil and leucovorin for the treatment of metastatic colorectal cancer where the dose of leucovorin is at least 200mg per square meter.
  • Use of irinotecan in combination with 5-fluorouracil and leucovorin for the treatment of metastatic colorectal cancer.
efficacy
5.0  (1)
side effects
0.0  (0)
danger
0.0  (0)

UNK

IRINOTECAN HYDROCHLORIDE [Irinotecan HydrochlorideC33H38N4O6ClH3H2O]
RX
-
100mg/5ml (20mg/ml) (injection injectable)
300mg/15ml (20mg/ml) (injection injectable)
40mg/2ml (20mg/ml) (injection injectable)
500mg/25ml (20mg/ml) (injection injectable)
Accord HlthcareNov 21, 2008
Actavis TotowaFeb 27, 2008
AkornSep 16, 2009
Cipla LtdFeb 20, 2008
Dr Reddys Labs LtdApr 15, 2010
Emcure Pharms LtdFeb 14, 2012
Fresenius Kabi OncolFeb 27, 2008
Fresenius Kabi UsaFeb 27, 2008
Hikma FarmaceuticaDec 20, 2010
Hisun Pharm HangzhouJan 28, 2009
HospiraFeb 27, 2008
Ingenus Pharms LlcMay 26, 2017
Jiangsu Hengrui MedDec 16, 2011
Mustafa Nevzat IlacMay 13, 2011
Pliva LachemaOct 31, 2008
Qilu Pharm Co LtdMay 3, 2016
Sandoz IncNov 12, 2009
Sun Pharma GlobalApr 21, 2008
Teva Pharms UsaFeb 27, 2008
West-ward Pharms IntDec 24, 2008
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ONIVYDE [Irinotecan HydrochlorideC33H38N4O6ClH3H2O]
RX
-
eq 43mg base/10ml (eq 4.3mg base/ml) (iv (infusion) injectable, liposomal)
Ipsen IncOct 22, 2015
  • Treatment of exocrine pancreatic cancer that has progressed on gemcitabine-based therapy, in combination with 5-fluorouracil and leucovorin.
  • Treatment of metastatic adenocarcinoma of the pancreas that has progressed on gemcitabine-based therapy, in combination with 5-fluorouracil and leucovorin, in a patient homozygous for the ugt1a1*28 allele.
  • Treatment of metastatic adenocarcinoma of the pancreas that has progressed on gemcitabine-based therapy, in combination with 5-fluorouracil and leucovorin.
  • Treatment of pancreatic cancer that has progressed on gemcitabine-based therapy, in combination with 5-fluorouracil and leucovorin.
  • Treatment of pancreatic cancer.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.